
|Articles|June 15, 2003
Verteporfin praised for sight-saving potential
Fort Lauderdale, FL-Novartis Ophthalmics and QLT Inc. have received the 2003 Helen Keller Prize for Innovation in Eye Care for their development of verteporfin for injection (Visudyne) therapy.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SpyGlass Pharma releases positive data from 2 trials of Bimatoprost Drug Pad-IOL System
2
Redefining glaucoma care: Where innovation meets clinical insight
3
Seborrheic dermatitis linked to multiple epithelial barrier diseases
4
Beyond the surface: Tackling complex dry eye cases
5



















































.png)


